Advisors
An advisor team of global standing.
Bloom X³ is supported by a senior advisor network across the United States and Japan — drawn from top-tier venture capital, pharmaceutical R&D leadership, academic research, and adjacent expertise. Together, they bring the operational depth and global reach that distinguish how we work.
Advisor categories
Venture Capital
General Partners and senior investors at leading U.S. and European life sciences venture firms.
Pharmaceutical Leadership
Former and current senior executives from global pharmaceutical R&D, business development, and corporate strategy.
Academic Research
Principal investigators and faculty from leading research universities in the United States and Japan.
Strategy & Operations
Specialists in legal, financial, regulatory, and operational dimensions of life sciences venture building.
The team
Tom Curran, Ph.D., FRS
Fellow of the Royal Society. Former Executive Director and CSO, Children’s Mercy Research Institute
Joe Bolen, Ph.D.
Executive Partner at MPM BioImpact; CEO at ORNA Therapeutics, Boston, MA
Guanghui Hu, Ph.D.
Serial Entrepreneur, Venture Partner & Founding Partner, Westfield BioVentures
Karuppiah Kannan, Ph.D.
Chief Scientific Officer, Nalam Therapeutics, Boston, MA
Our advisor engagement is selective and ongoing. Many introductions are made on a confidential basis through Bloom X³’s network — we welcome conversations with prospective partners who would benefit from access to this group.
Get in touch →